Skip to content

QUALYVERSE

Active Risk: not assessed Private limited companyfounded 2025active for less than a yearVilain XIIII-straat 17A, 1050 IxellesKBO/BCE: BE 1031.950.237

Identity

Enterprise number
1031.950.237
VAT number
BE 1031.950.237
Peppol ID
0208:1031950237
Other Peppol ID
9925:BE1031950237
Legal form
Private limited company
Status
Active, normal situation
Founded
19-12-2025
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December
deed of 23-12-2025 (in French)
First financial yearThe first financial year after incorporation can be shorter or longer than twelve months.
To 31-12-2026, first annual accounts due by 31-07-2027
deed of 23-12-2025
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Monday of May at 18:00
deed of 23-12-2025 (in French)
Peppol
Reachable since 30-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
QUALYVERSE in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 23-12-2025 (in French)
Registered office in the articlesThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
Brussels-Capital Region
deed of 23-12-2025 (in French)

Activities

NACEBEL 2025
PurposeThe purpose describes the activities the company may carry out under its articles.
“La recherche en santé publique et en médecine (y compris les maladies rares/médicaments orphelins)…”
6 activities
  1. La recherche en santé publique et en médecine (y compris les maladies rares/médicaments orphelins)
  2. La conception et la réalisation d'enquêtes médicales en Europe
  3. La recherche dans le cadre du « burden of disease »
  4. Le soutien au développement de médicaments (y compris les médicaments orphelins)
  5. Le développement de modèles précliniques et d'outils analytiques pour les candidats-médicaments, en particulier les médicaments orphelins (conception et évaluation de modèles précliniques, analyse de données)
  6. La création et licence de logiciels propriétaires (outils analytiques, algorithmes d'IA, plateformes d'enquête, modèles précliniques)
deed of 23-12-2025 (in French)

Registered office and establishments

1 establishment
Establishment Start date Unit number
Vilain XIIII-straat 17A registered office 1050 Ixelles 19-12-2025 2.385.236.631

Buildings and parcels at the address

Ground area
340 m²
Buildings
235 m²
Volume, LiDAR
4,690 m³
Tallest building
21.9 m
Buildings to scale, each on its own parcel
235 m², 21.9 m 235 m², 21.9 m

Location

registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Parcels

ParcelArea Buildings Height / floors
21444B0059/00P005 · registered office340 m² 1 · 235 m² 21.9 m · 7

Next steps

Documents and sources